Average Co-Inventor Count = 6.17
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (21 from 3,681 patents)
2. Flexus Biosciences, Inc. (7 from 8 patents)
3. Syngene International Limited (4 from 7 patents)
4. Innate Tumor Immunity, Inc. (3 from 21 patents)
5. Other (1 from 832,680 patents)
30 patents:
1. 12391675 - NLRP3 modulators
2. 12171756 - NLRP3 modulators
3. 12145927 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
4. 12059420 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
5. 11932601 - Immunoregulatory agents
6. 11649212 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
7. 11447449 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
8. 11344543 - NLRP3 modulators
9. 11242319 - Immunoregulatory agents
10. 11066383 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
11. 11066392 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
12. 10696648 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
13. 10689331 - IDO inhibitors
14. 10633342 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
15. 10544099 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use